The shareholders of TAP Biosystems Group have approved Sartorius Stedim Biotech’s takeover offer valued at approximately $44 million. The transaction is expected to close at the end of the year.   The acquisition expands Sartorius’ bioprocess portfolio in the area of fermentation, particularly in the early phases of product and process development. TAP Biosystems, headquartered in Royston, UK, specializes in the design and development of small scale, multi-parallel fermentation and cell culture ...